FDA 483 Observation Resolution

FDA 483 observation resolution addresses regulatory inspector findings requiring corrective action. Observations identify non-compliance with regulatory requirements. Severity assessment determines whether immediate correction or comprehensive investigation applies. Corrective action development implements lasting improvements preventing recurrence. Regulatory documentation demonstrates compliance establishment.

Repeat observations indicate inadequate corrective action requiring escalation. Substantiation demonstrating effectiveness includes multiple evidence sources. Timeline commitments establish specific completion deadlines. Regulatory agencies verify observation resolution before approval progression. Unresolved observations block regulatory progress.